LANCOVUTIDE

UNII:	BPR0F3X56H
Formula:	C₈₉H₁₂₅N₂₃O₂₅S₃
Preferred Substance Name:	LANCOVUTIDE
InChIKey:	SFWLDKQAUHFCBS-AOEYGKNYSA-N
GSRS Full Record:	BPR0F3X56H i

1391-36-2
ANCOVENIN, 2-L-LYSINE-6-(3-AMINOALANINE)-10-L-PHENYLALANINE-12-L-PHENYLALANINE-13-L-VALINE-15-(ERYTHRO-3-HYDROXY-L-ASPARTIC ACID)-, CYCLIC (6->19)-IMINE
DURAMYCIN
LANCOVUTIDE [INN]
LANCOVUTIDE [WHO-DD]
LEUCOPEPTIN
L-LYSINE, L-CYSTEINYL-L-LYSYL-L-GLUTAMINYL-D-CYSTEINYL-L-CYSTEINYL-3-AMINOALANYL-L-PHENYLALANYLGLYCYL-L-PROLYL-L-PHENYLALANYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-L-PHENYLALANYL-L-VALYL-L-CYSTEINYL-(3R)-3-HYDROXY-L-.ALPHA.-ASPARTYLGLYCYL-L-ASPARAGINYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-, CYCLIC-IMINE, CYCLIC (1->18),(4->14),(5->11)-TRIS(THIOETHER)
MOLI1901
MOLI-1901

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LANCOVUTIDE

Synonyms and Mappings

Resources